Sherzod Abdullaev
Ism variantlari: Sherzod S. Abdullaev
- Soʻnggi maʼlum muassasa:
- Tashkent Pediatric Medical Institute
- ORCID:
- 0000-0003-0640-5976
1
h-indeks
0
i10-indeksi
3
Iqtiboslar
43
Asarlar
Vaqt boʻyicha
Vaqt boʻyicha tahlil
Iqtibos sharhi
Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)
- Nashrlar
- Iqtiboslar
Iqtibos tarixi
Nashr tarixi
h-indeks evolyutsiyasi
Yillar boʻyicha jamlangan h-indeks
Eng koʻp iqtibos qilingan asarlar
- SAT-334 DISPARITIES IN TRANSPLANTATION ACCESS ACROSS DIFFERENT COUNTRIES: AN ISN FELLOWS COLLABORATIVE STUDY20200 iqtibos
- P0213CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: RISK OF COMPLICATIONS20200 iqtibos
- P0317EARLY MARKERS OF RENAL INJURY AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME20200 iqtibos
- Epidemiological, clinical and morphological aspects of kidney damage in COVID-1920210 iqtibos
- MO123USE OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE*20210 iqtibos
- POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION20210 iqtibos
- MO528INFLUENCE OF CARDIOVASCULAR DISEASES ON SURVIVAL RATES IN DIALYSIS PATIENTS IN A COHORT OF THE UZBEK POPULATION20210 iqtibos
- MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION20210 iqtibos
- MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF20220 iqtibos
- POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF20220 iqtibos
Hammualliflar
- Ranokhon Igamberdieva28 ta umumiy asar2020–2026
- Olimkhon Sharapov16 ta umumiy asar2021–2026
- Botir Daminov3 ta umumiy asar2022–2026
- Музаффар Илхомжон Асомов2 ta umumiy asar2025
- Ismoil Rashidov2 ta umumiy asar2020–2023
- Abduzhappar Gaipov2 ta umumiy asar2020–2023
- Aziz Daminov1 ta umumiy asar2026
- Rakhimjon Tursunbayev1 ta umumiy asar2025
- Alimzhan Muxunov1 ta umumiy asar2023
- N. Bulanov1 ta umumiy asar2023